Ameliorative properties of quercetin in the treatment of traumatic brain injury: a mechanistic review based on underlying mechanisms

Didn't your competent? doctor start using this 6 years ago? Oh, you don't have a competent doctor , do you? Will your doctor ensure that further research gets done for stroke?

• Quercetin (8 posts to January 2018)

Ameliorative properties of quercetin in the treatment of traumatic brain injury: a mechanistic review based on underlying mechanisms

• Golale Tanhai,
• Amir Modarresi Chahardehi,
• Mohammad Ali Sohrabi,
• Maryam Afshoon,
• Parsa Saberian,
• Maryam Pourshams,
• Darioush Ghasemi,
• Seyed Mohammad Motaghi,
• Reza Arefnezhad &
• Zahra Niknam 

Abstract

Traumatic brain injury (TBI) is a leading cause of disability worldwide, with an estimated annual incidence of 27–69 million. TBI is a severe condition that can lead to high mortality rates and long-term cognitive, behavioral, and physical impairments in young adults. It is a significant public health concern due to the lack of effective treatments available. Quercetin, a natural flavonoid found in various fruits and vegetables, has demonstrated therapeutic potential with anti-inflammatory, antioxidant, and neuroprotective properties. Recently, some evidence has accentuated the ameliorating effects of quercetin on TBI. This review discusses quercetin’s ability to reduce TBI-related damage by regulating many cellular and molecular pathways. Quercetin in vitro and in vivo studies exhibit promise in reducing inflammation, oxidative stress, apoptosis, and enhancing cognitive function post-TBI. Further clinical investigation into quercetin’s therapeutic potential as a readily available adjuvant in the treatment of TBI is warranted in light of these findings. This review adds to our knowledge of quercetin’s potential in treating TBI by clarifying its mechanisms of action.

This is a preview of subscription content, log in via an institution to check access.